Zenta Tsuchihashi

Senior Director, Translational Patient Safety, Clinical Safety & Pharmacovigilance Daiichi Sankyo

Seminars

Monday 23rd February 2026
Exploring Predictive Biomarkers for ADC-Induced Pulmonary Toxicities: The Enhertu Experience
10:30 am
  • Overviewing biomarkers for ADC-Induced pulmonary toxicities
  • Defining responsibility by discussing who should lead clinical ADC sample-based translational research for safety
  • Addressing the gap between preclinical toxicity teams and clinical safety teams
  • Case study: Exploring ILD concerns in HER2- targeted ADCs – how are biomarkers in blood helping refine prediction and how can we monitor and treat ADC toxicities?
Zenta Tsuchihashi Speaker Photo - 16th World ADC London Summit